Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Cannabix Technologies ( (TSE:BLO) ).
Cannabix Technologies has begun a phased commercial rollout of its Marijuana Breath Test system, delivering units to select customers in multiple industries and preparing to scale production. The platform combines a handheld Breath Collection Unit, disposable Breath Cartridges and a laboratory-developed test to detect recent cannabis use within roughly four hours of consumption, aiming to give employers and law enforcement a more relevant measure of impairment.
The launch follows independent peer-reviewed validation in the Journal of Analytical Toxicology and integration of the system into Omega Laboratories’ certified drug-testing workflows. Cannabix has established manufacturing, QA procedures and a recurring revenue model based on disposable cartridges, positioning the company to benefit from growing legalization and demand for scientifically grounded, recent-use cannabis detection in safety-critical markets.
The most recent analyst rating on (TSE:BLO) stock is a Hold with a C$0.48 price target. To see the full list of analyst forecasts on Cannabix Technologies stock, see the TSE:BLO Stock Forecast page.
Spark’s Take on BLO Stock
According to Spark, TipRanks’ AI Analyst, BLO is a Neutral.
The score is primarily held down by very weak financial performance (minimal revenue, large losses, and ongoing cash burn) despite low leverage. Technical indicators are modestly supportive in the near term, but valuation is constrained by negative earnings and no dividend data.
To see Spark’s full report on BLO stock, click here.
More about Cannabix Technologies
Cannabix Technologies Inc. develops marijuana and alcohol breath-testing technologies for workplaces, law enforcement and other safety-sensitive settings. Its flagship Marijuana Breath Test focuses on detecting recent cannabis use by targeting delta-9 THC in breath, addressing demand for tools that distinguish current impairment from past consumption in regulated and high-risk environments.
YTD Price Performance: -12.07%
Average Trading Volume: 33,073
Technical Sentiment Signal: Sell
Current Market Cap: C$61.75M
Learn more about BLO stock on TipRanks’ Stock Analysis page.